Featured Research

from universities, journals, and other organizations

Protein levels could signal that a child will develop diabetes, researchers believe

Date:
April 26, 2011
Source:
Georgia Health Sciences University
Summary:
Decreasing blood levels of a protein that helps control inflammation may be a red flag that could help children avoid type 1 diabetes, researchers say.

Georgia Health Sciences University Researchers Sharad Purohit and Jin-Xiong She may have found a red flag that could help children avoid type 1 diabetes, researchers say.
Credit: Phil Jones/GHSU Photographer

Decreasing blood levels of a protein that helps control inflammation may be a red flag that could help children avoid type 1 diabetes, researchers say.

Georgia Health Sciences University researchers are looking at blood levels of interleukin-1 receptor antagonist, or IL-1ra, in children being closely followed because their genes put them at risk for type 1 diabetes. They also are looking at diabetic mice missing IL-1ra to see how the protein deficiency affects immune function and destruction of insulin-producing islet beta cells.

"We want to know if we can use IL-1ra levels to identify children who will soon develop the disease, then use IL-1 inhibitors to prevent it," said Dr. Sharad Purohit, biochemist in the GHSU Center for Biotechnology and Genomic Medicine.

IL-1ra helps reduce inflammation and Purohit's preliminary evidence suggests that low levels predict inflammation is increasing and the immune system is going to attack insulin-producing cells. A three-year, $500,000 grant from the Juvenile Diabetes Research Foundation will help him explore the hypothesis in the blood of about 2,500 children as well as the diabetic mice.

Il-1 inhibitors already are used to treat rheumatoid arthritis, where inflammation destroys joints. Clinical trials are underway in type 1 diabetes and to see if an inhibitor can halt the islet cell destruction that occurs in type 1 diabetes as well.

While acknowledging the inhibitor may improve type 1diabetes outcome, GHSU scientists want to know if it can also be used preventively, said Dr. Jin-Xiong She, Director of the Center for Biotechnology and Genomic Medicine.

IL-1ra competes with its counterpart IL-1beta for the IL-1 receptor. In type 1 diabetes, inflammation-promoting IL-1beta appears to be winning. "It's a balance; it's a competition," She said. "There is always a balance between beta cell production and destruction and any process that can change the balance can push you to disease or help you recover from it. In this case, we believe that knowing the balance is off can actually help prevent disease."

Type 1 diabetes typically presents by puberty, as the body's immune system inexplicably turns against the pancreas' insulin-producing cells. By the time the first symptoms occur, such as increased appetite in the face of significant weight loss, as many as 90 percent of the beta cells may be destroyed, leaving a child facing a lifetime of insulin dependency and often complications such as cardiovascular damage and vision loss. Much like the lifestyle-related type 2 diabetes, the incidence of type 1 is increasing.


Story Source:

The above story is based on materials provided by Georgia Health Sciences University. Note: Materials may be edited for content and length.


Cite This Page:

Georgia Health Sciences University. "Protein levels could signal that a child will develop diabetes, researchers believe." ScienceDaily. ScienceDaily, 26 April 2011. <www.sciencedaily.com/releases/2011/04/110425101154.htm>.
Georgia Health Sciences University. (2011, April 26). Protein levels could signal that a child will develop diabetes, researchers believe. ScienceDaily. Retrieved July 30, 2014 from www.sciencedaily.com/releases/2011/04/110425101154.htm
Georgia Health Sciences University. "Protein levels could signal that a child will develop diabetes, researchers believe." ScienceDaily. www.sciencedaily.com/releases/2011/04/110425101154.htm (accessed July 30, 2014).

Share This




More Health & Medicine News

Wednesday, July 30, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Generics Eat Into Pfizer's Sales

Generics Eat Into Pfizer's Sales

Reuters - Business Video Online (July 29, 2014) Pfizer, the world's largest drug maker, cut full-year revenue forecasts because generics could cut into sales of its anti-arthritis drug, Celebrex. Fred Katayama reports. Video provided by Reuters
Powered by NewsLook.com
Nigeria Ups Ebola Stakes on 1st Death

Nigeria Ups Ebola Stakes on 1st Death

Reuters - Business Video Online (July 29, 2014) Nigerian authorities have shut and quarantined a Lagos hospital where a Liberian man died of the Ebola virus, the first recorded case of the highly-infectious disease in Africa's most populous economy. David Pollard reports Video provided by Reuters
Powered by NewsLook.com
Running 5 Minutes A Day Might Add Years To Your Life

Running 5 Minutes A Day Might Add Years To Your Life

Newsy (July 29, 2014) According to a new study, just five minutes of running or jogging a day could add years to your life. Video provided by Newsy
Powered by NewsLook.com
Ebola Outbreak Poses Little Threat To U.S.: CDC

Ebola Outbreak Poses Little Threat To U.S.: CDC

Newsy (July 29, 2014) The Ebola outbreak in West Africa poses little threat to Americans, according to officials with the Centers for Disease Control and Prevention. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins